GlassScriptPhysician profile
Patrick S Bucayu
NPI 1598379760
$5,863.64
in general payments reported to CMS, 2019-2025
33 companies · $1,998 in 2025
The $1,998 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $1,330 · 2023: $1,098 · 2024: $1,237 · 2025: $1,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,229 · Education: $65.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,229.20 |
| Education | $65.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,008.15 | 2022-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $878.39 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $348.44 | 2022-2025 | Erleada |
| Abbvie INC. | $309.85 | 2022-2025 | |
| Teleflex LLC | $303.90 | 2022-2024 | Urolift |
| Procept Biorobotics Corporation | $294.85 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Ferring Pharmaceuticals INC. | $286.27 | 2024-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $275.39 | 2022-2024 | Xiaflex, Aveed, Edex |
| Coloplast Corp | $269.79 | 2021-2024 | |
| Verity Pharmaceuticals INC. | $255.73 | 2023-2025 | Trelstar, Tlando |
| Halozyme INC | $214.47 | 2023 | |
| Urogen Pharma, INC. | $180.27 | 2022-2025 | Jelmyto |
| Endo USA, INC. | $155.13 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $154.54 | 2022-2023 | Rezum Generator |
| Antares Pharma, INC. | $142.78 | 2021-2025 | Xyosted |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $129.06 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $111.33 | 2021-2025 | Keytruda, Welireg |
| Accord Healthcare, INC. | $99.53 | 2022-2025 | |
| Urovant Sciences INC | $72.63 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.99 | 2022 | |
| Astellas Pharma US INC | $44.48 | 2021-2023 | Myrbetriq |
| Tolmar Pharmaceuticals, INC. | $37.09 | 2022 | |
| Clarus Therapeutics INC. | $32.48 | 2021 | |
| Amgen INC. | $30.02 | 2021 | |
| 180 Medical, INC. | $25.00 | 2022 | |
| Tolmar, INC. | $23.93 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.21 | 2025 | |
| Myovant Sciences INC. | $22.70 | 2022 | |
| Blue Earth Diagnostics | $20.00 | 2021 | |
| Abc Home Medical Supply, INC. | $15.70 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.96 | 2025 | Lynparza |
| Vertex Pharmaceuticals Incorporated | $14.95 | 2024 | |
| Allergan, INC. | $14.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Bucayu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.